Miguel Vargas-Morales

Dr. Miguel Vargas-Morales

INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIA - INER, Mexico City, Ciudad de México, Mexico

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2022 in Cells
Verified
Journal Article
Open access
PDF file
Yair RomeroYair Romero
Yair Romero
YBYalbi Itzel Balderas-Martinez
Yalbi Itzel Balderas-Martinez
MVMiguel Vargas-Morales
Miguel Vargas-Morales
MLManuel de Jesus Castillejos López
Manuel de Jesus Castillejos López
JVJoel Armando Vazquez-Perez
Joel Armando Vazquez-Perez
AAArnoldo Aquino-Gálvez
Arnoldo Aquino-Gálvez
Idiopathic pulmonary fibrosis (IPF) is an aging-associated disease characterized by exacerbated extracellular matrix deposition that disrupts oxygen exchange. Hypoxia and its transcription factors (HIF-1α and 2α) influence numerous circuits that could perpetuate fibrosis by increasing myofibroblasts differentiation and by promoting extracellular matrix accumulation. Therefore, this work aimed to elucidate the signature of hypoxia in the transcriptomic circuitry of IPF-derived fibroblasts. To determine this transcriptomic signature, a gene expression analysis with six lines of lung fibroblasts under normoxia or hypoxia was performed: three cell lines were derived from patients with IPF, and three were from healthy donors, a total of 36 replicates. We used the Clariom D platform, which allows us to evaluate a huge number of transcripts, to analyze the response to hypoxia in both controls and IPF. The control′s response is greater by the number of genes and complexity. In the search for specific genes responsible for the IPF fibroblast phenotype, nineteen dysregulated genes were found in lung fibroblasts from IPF patients in hypoxia (nine upregulated and ten downregulated). In this sense, the signaling pathways revealed to be affected in the pulmonary fibroblasts of patients with IPF may represent an adaptation to chronic hypoxia.

30 June 2026 in Cells
Verified
Journal Article
Open access
PDF file
Yair RomeroYair Romero
Yair Romero
YBYalbi Itzel Balderas-Martinez
Yalbi Itzel Balderas-Martinez
MVMiguel Vargas-Morales
Miguel Vargas-Morales
MLManuel de Jesus Castillejos López
Manuel de Jesus Castillejos López
JVJoel Armando Vazquez-Perez
Joel Armando Vazquez-Perez
AAArnoldo Aquino-Gálvez
Arnoldo Aquino-Gálvez
An error occurred in the original publication